(3R,4S)-4-(4-(Benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)azetidin-2-one
97%
- Product Code: 113247
CAS:
163222-32-0
| Molecular Weight: | 499.55 g./mol | Molecular Formula: | C₃₁H₂₇F₂NO₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00937870 | |
| Melting Point: | Boiling Point: | 706.462°C at 760 mmHg | |
| Density: | Storage Condition: | Room temperature, dry and sealed |
Product Description:
This compound is primarily utilized in pharmaceutical research, particularly in the development of enzyme inhibitors. It has shown potential in targeting specific enzymes involved in inflammatory and metabolic disorders. Its unique structure allows it to interact with enzyme active sites, making it a candidate for drug development in conditions like diabetes and autoimmune diseases. Additionally, its fluorophenyl and benzyloxy groups contribute to its stability and binding affinity, enhancing its efficacy in preclinical studies. Researchers are exploring its use in creating novel therapeutic agents with improved selectivity and reduced side effects.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White Solid |
| Purity (%) | 96.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | ฿2,530.00 |
+
-
|
| 1.000 | 10-20 days | ฿5,070.00 |
+
-
|
| 5.000 | 10-20 days | ฿13,700.00 |
+
-
|
(3R,4S)-4-(4-(Benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)azetidin-2-one
This compound is primarily utilized in pharmaceutical research, particularly in the development of enzyme inhibitors. It has shown potential in targeting specific enzymes involved in inflammatory and metabolic disorders. Its unique structure allows it to interact with enzyme active sites, making it a candidate for drug development in conditions like diabetes and autoimmune diseases. Additionally, its fluorophenyl and benzyloxy groups contribute to its stability and binding affinity, enhancing its efficacy in preclinical studies. Researchers are exploring its use in creating novel therapeutic agents with improved selectivity and reduced side effects.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :